[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-447655-105":59,"doc-detail-447655-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","senate-bill-no-200-pharmacist-scope-expansion-and-therapy-protocols","SENATE BILL No. 200 - Pharmacist Scope Expansion and Therapy Protocols","","Kansas Senate Bill No. 200 amends the Kansas pharmacy act to expand pharmacists’ scope of practice. It allows pharmacists, under a statewide protocol, to initiate therapy for specified health conditions such as influenza, streptococcal pharyngitis, and urinary tract infection. The bill also updates K.S.A. 65-1626a and addresses collaborative drug therapy management, including protocol adoption considerations based on patient age, FDA approval, in-person interactions, and administration method.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":35,"@type":76,"position":81},"https://docshare.wps.com/document/healthcare/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/senate-bill-no-200-pharmacist-scope-expansion-and-therapy-protocols/447655/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/senate-bill-no-200-pharmacist-scope-expansion-and-therapy-protocols/447655.png","ImageObject",300,407,{"name":92,"@type":93},"Miles","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-30","2026-09-29",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What does Senate Bill No. 200 change about pharmacists’ scope of practice in Kansas?","Question",{"text":112,"@type":113},"It expands pharmacists’ authority to initiate therapy within a statewide protocol for specified health conditions, and it amends K.S.A. 65-1626a accordingly.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which health conditions does the bill authorize pharmacists to initiate therapy for under the statewide protocol?",{"text":117,"@type":113},"The bill lists influenza, streptococcal pharyngitis, and urinary tract infection.",{"name":119,"@type":110,"acceptedAnswer":120},"How is a statewide protocol for each condition adopted and what factors must be considered?",{"text":121,"@type":113},"A collaborative drug therapy management advisory committee may adopt protocols for listed conditions and must consider therapy appropriateness based on the patient’s age, FDA approval, in-person interactions, and the method of administration.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},447655,1791087708,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":34,"category_name":35,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":19,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":52,"preview_page_count":4},13056703019404,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","As Amended by Senate Committee  \nSession of 2021  \nSENATE BILL No. 200  \nBy Committee on Public Health and Welfare  \n2-10  \n1 AN ACT concerning pharmacists and pharmacy; relating to the state board  \n2 of pharmacy; expanding the pharmacist's scope of practice to include  \n3 point-of-care testing for and treatment of certain health conditions;  \n4 amending K.S.A. 65-1626a and repealing the existing section. 5  \n6 Be it enacted by the Legislature of the State of Kansas:  \n7 ~~New Section 1. A pharmacist may independently test or screen for~~  \n8 ~~ and initiate therapy pursuant to a state-wide protocol established by the~~  \n9 ~~ state board of pharmacy for health conditions of individuals who are  ~~10 ~~ eligible to receive the testing or screening service~~.~~ For purposes of this ~~11 ~~ section, a health condition is a condition that is generally managed with ~~12 ~~minimal treatment or self-care and includes~~,~~ but is not limited to:~~  \n13 ~~ (a) Influenza;~~  \n14 ~~ (b) streptococcus;~~  \n15 ~~ (c) COVID-19;~~  \n16 ~~ (d) pre-exposure prophylaxis; ~~  \n17 ~~ (e) post-exposure prophylaxis; or~~  \n18 ~~ (f) a condition for which its diagnostic test is waived under the ~~  \n19 ~~ federal clinical laboratory improvement amendments of 1988.~~​  \n20 New Section 1. (a) A pharmacist may initiate therapy within the  \n21 framework of a statewide protocol for the following health conditions:  \n22 (1) Influenza;  \n23 (2) streptococcal pharyngitis; or  \n24 (3) urinary tract infection.  \n25 (b) The collaborative drug therapy management advisory committee  \n26 may adopt a statewide protocol for each condition listed in subsection  \n27 (a). The committee shall consider appropriateness of therapy based  \n28 upon:  \n29 (1) The patient's age;  \n30 (2) approval by the United States food and drug administration;  \n31 (3) in-person interactions; and  \n32 (4) the method of administration.  \n33 Sec. 2. K.S.A. 65-1626a is hereby amended to read as follows: 65- 34 1626a. (a) For the purpose of the pharmacy act of the state of Kansas, the  \n35 following~~ persons~~ individuals shall be deemed to be engaged in the 36 practice of pharmacy:  \nSB 200—[Am. by](Am. by) SC 2  \n1 (1) ~~Persons~~Individuals who publicly profess to be a pharmacist, or  \n2 publicly profess to assume the duties incident to being a pharmacist and  \n3 their knowledge of drugs or drug actions, or both; and  \n4 (2) ~~persons~~individuals who attach to their name any words or  \n5 abbreviation indicating that they are a pharmacist licensed to practice  \n6 pharmacy in Kansas.  \n7 (b) As used in this section:  \n8 (1) \"Practice of pharmacy\" means:  \n9 (A) The interpretation and evaluation of prescription orders;  \n10 (B) the compounding, dispensing and labeling of drugs and devices 11 pursuant to prescription orders;  \n12 (C) the administering of vaccine pursuant to a vaccination protocol;  \n13 (D) the participation in drug selection according to state law and 14 participation in drug utilization reviews;  \n15 (E) the proper and safe storage of prescription drugs and prescription 16 devices and the maintenance of proper records thereof in accordance with 17 law;  \n18 (F) consultation with patients and other health care practitioners 19 about the safe and effective use of prescription drugs and prescription 20 devices;  \n21 (G) performance of collaborative drug therapy management pursuant 22 to a written collaborative practice agreement with one or more physicians 23 who have an established physician-patient relationship;~~ and~~  \n24 (H) participation in the offering or performing of those acts, services, 25 operations or transactions necessary in the conduct, operation, 26 management and control of a pharmacy; and  \n27 (I) ~~ the initiation of drugs~~,~~ drug categories or devices that are~~ ~~ ~~  \n28 ~~ initiated in accordance with the product~~'~~s federal food and drug  ~~29 ~~ administration-approved labeling and limited to conditions listed below~~ ~~ ~~  \n30 ~~ that:~~  \n31 ","cbCaig2VZ15Vmi72","https://ap.wps.com/l/cbCaig2VZ15Vmi72","pdf",105846,"English","# Overview\n## Expanded pharmacist therapy scope\n## Statewide protocol and advisory committee considerations\n## Amendments to K.S.A. 65-1626a","[{\"question\":\"What does Senate Bill No. 200 change about pharmacists’ scope of practice in Kansas?\",\"answer\":\"It expands pharmacists’ authority to initiate therapy within a statewide protocol for specified health conditions, and it amends K.S.A. 65-1626a accordingly.\"},{\"question\":\"Which health conditions does the bill authorize pharmacists to initiate therapy for under the statewide protocol?\",\"answer\":\"The bill lists influenza, streptococcal pharyngitis, and urinary tract infection.\"},{\"question\":\"How is a statewide protocol for each condition adopted and what factors must be considered?\",\"answer\":\"A collaborative drug therapy management advisory committee may adopt protocols for listed conditions and must consider therapy appropriateness based on the patient’s age, FDA approval, in-person interactions, and the method of administration.\"}]","SENATE BILL No. 200 - Pharmacist Scope Expansion and Therapy Protocols | PDF",1790722074]